ATOSSA THERAPEUTICS, INC. (ATOS) › Operating IncomeATOSSA THERAPEUTICS, INC. (ATOS) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2011: -$3.43M2012: -$5.07M2013: -$10.78M2014: -$12.17M2015: -$12.76M2016: -$7.97M2017: -$7.65M2018: -$11.43M2019: -$17.27M2020: -$14.61M2021: -$20.52M2022: -$27.69M2023: -$31.38M2024: -$27.62M2025: -$37.14M-$37.14M2011Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$37.14M-34.5%2024-$27.62M+12.0%2023-$31.38M-13.3%2022-$27.69M-34.9%2021-$20.52M-40.5%2020-$14.61M+15.4%2019-$17.27M-51.0%2018-$11.43M-49.5%2017-$7.65M+4.0%2016-$7.97M+37.5%2015-$12.76M-4.8%2014-$12.17M-12.9%2013-$10.78M-112.8%2012-$5.07M-47.8%2011-$3.43M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share